Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Bouffard

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Presse Medicale (Paris, France : 1983)|November 30, 1991
[Orthotopic liver transplantation for severe amanita phalloides poisoning]M Pouyet, P Caillon, C Ducerf, et al.
Presse Medicale (Paris, France : 1983)|June 23, 1984
[Secreting carcinoid tumor. Hemodynamic study of an intraoperative attack of flushing]D Perrot, M C Graber, J J Lehot, et al.
The American Journal of Physiology|November 1, 1994
Effects of glucose-to-lipid ratio and type of lipid on substrate oxidation rate in patientsB Delafosse, J P Viale, S Tissot, et al.
Transplantation Proceedings|February 1, 1989
Liver transplantation--energy expenditure, nitrogen loss, and substrate oxidation rate in the first two postoperative daysB Delafosse, J L Faure, Y Bouffard, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2002
Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenograftsHenriette Gourdeau, Philippe Genne, Salam Kadhim, et al.
The American Journal of Clinical Nutrition|February 1, 1993
Recovery of [13C]bicarbonate as respiratory 13CO2 in mechanically ventilated patientsS Tissot, B Delafosse, S Normand, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Oligonucleotide modulation of multidrug resistanceD Y Bouffard, T Ohkawa, H Kijima, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Anti-oncogene ribozymes for cancer gene therapyA Irie, H Kijima, T Ohkawa, et al.
BMC Cancer|July 5, 2007
Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancerVijaya L Damaraju, David Y Bouffard, Clarence K W Wong, et al.
Critical Care Medicine|November 9, 2001
Compliance with triage to intensive care recommendationsE Azoulay, F Pochard, S Chevret, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Presse Medicale (Paris, France : 1983)|November 30, 1991
[Orthotopic liver transplantation for severe amanita phalloides poisoning]M Pouyet, P Caillon, C Ducerf, et al.
Presse Medicale (Paris, France : 1983)|June 23, 1984
[Secreting carcinoid tumor. Hemodynamic study of an intraoperative attack of flushing]D Perrot, M C Graber, J J Lehot, et al.
The American Journal of Physiology|November 1, 1994
Effects of glucose-to-lipid ratio and type of lipid on substrate oxidation rate in patientsB Delafosse, J P Viale, S Tissot, et al.
Transplantation Proceedings|February 1, 1989
Liver transplantation--energy expenditure, nitrogen loss, and substrate oxidation rate in the first two postoperative daysB Delafosse, J L Faure, Y Bouffard, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2002
Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenograftsHenriette Gourdeau, Philippe Genne, Salam Kadhim, et al.
The American Journal of Clinical Nutrition|February 1, 1993
Recovery of [13C]bicarbonate as respiratory 13CO2 in mechanically ventilated patientsS Tissot, B Delafosse, S Normand, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Oligonucleotide modulation of multidrug resistanceD Y Bouffard, T Ohkawa, H Kijima, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Anti-oncogene ribozymes for cancer gene therapyA Irie, H Kijima, T Ohkawa, et al.
BMC Cancer|July 5, 2007
Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancerVijaya L Damaraju, David Y Bouffard, Clarence K W Wong, et al.
Critical Care Medicine|November 9, 2001
Compliance with triage to intensive care recommendationsE Azoulay, F Pochard, S Chevret, et al.
Pageof 6